3 completed, 2 active not recruiting, 1 recruiting, 1 unknown. 3 Phase 2, 2 Not applicable, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Withdrawn 1 |
| Not applicable | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Chronic Rejection of Lung Transplant: new trials by email Literature Review of Chronic Rejection of Lung Transplant trials Research Report on Chronic Rejection of Lung Transplant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prediction of Lung Transplant Outcome Research Blood Sampling and Biocollection - Graft Dysfunction, Lung Transplantation | Not applicable | Active not recruiting | Hopital Foch | 4200 | 2025-06-17 | 2026-01-21 |
| Noninvasive Early Detection of Lung Allograft Dysfunction After Lung Transplantation With Multiple Breath Washout Test Multiple Breath Washout (MBW) tests - Chronic Rejection of Lung Transplant | Not applicable | Recruiting | University of Zurich | 90 | 2023-03-01 | 2023-05-16 |
| Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS) Assigned Interventions - Disorder Related to Lung Transplantation, Chronic Rejection of Lung Transplant | Phase 2 | Withdrawn | University of Maryland, Baltimore | 2020-06-30 | 2023-05-06 | |
| Advanced Immunoclinical Phenotyping of Rejection in Lung Transplant Lung transplant recipient without MRI imaging, Lung transplant recipient with MRI imaging - Chronic Rejection of Lung Transplant | Phase 2 | Active not recruiting | University of Virginia | 1200 | 2019-04-01 | 2024-11-18 |
| Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1) Liposomal Cyclosporine A, standard of care - Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant | Phase 3 | Completed | Zambon SpA | 62 | 2019-03-26 | 2025-10-27 |
| Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2) Liposomal Cyclosporine A, Standard of Care - Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant | Phase 3 | Completed | Zambon SpA | 169 | 2019-03-26 | 2026-02-10 |
| Exhaled Breath Particles in Lung Transplantation Lung Transplant Rejection, Primary Graft Dysfunction | Unknown | Lund University Hospital | 150 | 2018-09-18 | 2022-05-16 | |
| Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients Liposomal aerosol cyclosporine, standard immune suppression, oral - Disorder Related to Lung Transplantation, Bronchiolitis Obliterans | Phase 1 / Phase 2 | Completed | University of Maryland, Baltimore | 21 | 2012-07-01 | 2023-06-01 |
Bronchiolitis Obliterans (3) · Rejection, Psychology (3) · Bronchiolitis Obliterans Syndrome (2) · Primary Graft Dysfunction (1)
Bronchial Diseases (4) · Bronchiolitis (4) · Bronchitis (4) · Lung Diseases (4) · Lung Diseases, Obstructive (4) · Respiratory Tract Diseases (4) · Behavior (3) · Social Behavior (3) · Graft vs Host Disease (2) · Immune System Diseases (2) · Organizing Pneumonia (2) · Bronchiolitis Obliterans (1) · Cardiovascular Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Sirolimus (2) · Standard of Care (2) · Tacrolimus (2) · Cyclosporine (1) · Mycophenolic Acid (1) · Prednisone (1)
University of Maryland, Baltimore (2) · Zambon SpA (2) · Hopital Foch (1) · Lund University Hospital (1) · University of Virginia (1) · University of Zurich (1)
United States (4) · France (3) · Belgium (2) · Germany (2) · Israel (2) · Spain (2) · United Kingdom (2) · Austria (1) · Denmark (1) · Sweden (1) · Switzerland (1)
Aldo T Iacono, MD (2) · Paola Castellani, MD (2) · Antoine Roux, Pr (1) · Carolin Steinack, MD (1) · Sandra Lindstedt, MD, PhD (1) · Yun M Shim, MD (1)
2018 (2), 2017 (1)